预防风险模型与身体脂肪分布和亚临床左心室功能障碍的关联
Kazutoshi Hirose1, Koki Nakanishi1,2, Masao Daimon1,3
1Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
American journal of preventive cardiology
|January 7, 2026
概括
预测心血管疾病风险的PREVENT评分与内脏脂肪增加和心脏功能障碍的早期迹象有关. 这突显了它在识别超越传统措施更高心血管风险的个人的实用性.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 风险分层是指风险的分层.
背景情况:
- 预防风险模型对心血管风险分层有希望.
- 它与身体脂肪分布和左心室 (LV) 机制的关联仍然未被探索.
研究的目的:
- 调查PREVENT风险评分,身体脂肪分布 (内脏和皮下脂肪) 和亚临床LV功能障碍之间的关系.
主要方法:
- 评估了517名没有心脏病的参与者.
- 计算了PREVENT分数,并将参与者按三角形分组.
- 用CT测量了内脏脂肪面积 (VFA) 和皮下脂肪面积 (SFA).
- 使用心声学评估LV全球纵向菌株 (LVGLS).
主要成果:
- 较高的PREVENT分数与明显更大的VFA相关,但不是SFA.
- 随着PREVENT风险得分的增加,LVGLS逐渐下降.
- 预防得分独立预测异常的LVGLS.
结论:
- PREVENT风险模型与内脏脂肪增加有关.
- 该模型还与亚临床左心室功能障碍相关,表明其更广泛的预测能力.
更多相关视频
相关概念视频
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Coronary Artery Disease III: Clinical Manifestations
317
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
317
Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393


